Latest Shareholder Interests News

ClearVue Technologies has boosted its capital raising to $6.25 million, with significant board participation and revised loan terms, while its Gen 3 Vision Glass secures crucial EN 1279-5 certification.

Australian Mines appoints Andrew Nesbitt as Managing Director and adds two new Non-Executive Directors, while unveiling a 1-for-5 share consolidation and director incentives linked to key project milestones.

The NSW Supreme Court has approved Aeris Resources' takeover of Peel Mining, setting in motion key dates for shareholder entitlements and trading suspension.

Novonix has secured A$20.7 million from an institutional placement at a 33% discount, alongside a A$3 million Share Purchase Plan for existing shareholders, aiming to fund production capacity expansion amid growing battery demand.

ALS Limited has confirmed its ordinary dividend of AUD 0.231 per share for the six months ending March 2026, introducing multi-currency payment options and appointing Macquarie Securities to manage on-market share purchases for its Dividend Reinvestment Plan.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

MC Mining has locked in nearly US$10 million through convertible promissory notes from its major shareholders, targeting the completion and ramp-up of its flagship Makhado hard coking coal project in South Africa.

Vitasora Health Limited has secured $4 million in a strongly oversubscribed placement, anchored by a $3 million cornerstone investment from private investor Bob Peters. The capital boost supports rapid growth in monthly billings and funds the company through expected cashflow breakeven in the second half of 2026.

Northern Star Resources acknowledges activist investor Elliott's stake and proposals, confirms ongoing CEO recruitment, and highlights progress on key projects while rejecting a sale process.

Burley Minerals has closed its Share Purchase Plan (SPP) after receiving applications beyond the $300,000 target, following a recent $700,000 placement. The company may scale back or accept all applications at its discretion, with shares expected to be issued on 12 June 2026.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Tasmea Limited (ASX: TEA) has announced a fully franked special dividend of 10.0 cents per share, returning approximately A$26.2 million to shareholders while reaffirming its FY26 earnings guidance and maintaining a positive outlook for FY27.